BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11473032)

  • 1. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.
    Yu L; Cuthbertson DD; Maclaren N; Jackson R; Palmer JP; Orban T; Eisenbarth GS; Krischer JP;
    Diabetes; 2001 Aug; 50(8):1735-40. PubMed ID: 11473032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.
    Krischer JP; Cuthbertson DD; Yu L; Orban T; Maclaren N; Jackson R; Winter WE; Schatz DA; Palmer JP; Eisenbarth GS
    J Clin Endocrinol Metab; 2003 Jan; 88(1):103-8. PubMed ID: 12519837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Prevention Trial 1: prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband.
    Yu L; Cuthbertson DD; Eisenbarth GS; Krischer JP
    Ann N Y Acad Sci; 2002 Apr; 958():254-8. PubMed ID: 12021118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
    Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
    J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
    Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
    Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.
    Verge CF; Gianani R; Kawasaki E; Yu L; Pietropaolo M; Jackson RA; Chase HP; Eisenbarth GS
    Diabetes; 1996 Jul; 45(7):926-33. PubMed ID: 8666144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
    Park Y; Lee H; Takino H; Abiru N; Kawasaki E; Eisenbarth GS
    Acta Diabetol; 2001; 38(1):51-6. PubMed ID: 11487177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of high-risk HLA-DQB1 alleles in Chilean type 1 diabetic patients and their parents: stratification by the presence of ICA or GAD65 autoantibodies.
    Pérez-Bravo F; Santos JL; Carrasco E; Calvillán M; Albala C; Puig-Domingo M; Piquer S; De Leiva A
    Autoimmunity; 2001; 33(4):285-91. PubMed ID: 11683403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
    Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
    Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
    J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type I diabetes.
    Yu L; Gianani R; Eisenbarth GS
    Diabetes; 1994 Oct; 43(10):1229-33. PubMed ID: 7926293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.
    Vardi P; Crisa L; Jackson RA
    Diabetologia; 1991 Feb; 34(2):93-102. PubMed ID: 2065854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.
    Decochez K; Truyen I; van der Auwera B; Weets I; Vandemeulebroucke E; de Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Pipeleers DG; Gorus FK;
    Diabetologia; 2005 Apr; 48(4):687-94. PubMed ID: 15756536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
    Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
    Alves LI; Davini E; Correia MR; Fukui RT; Santos RF; Cunha MR; Rocha DM; Volpini WM; Silva ME
    J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.